Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acerus Pharmaceuticals (ASPCQ)
OTHER OTC:ASPCQ
Holding ASPCQ?
Track your performance easily
ASPCQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.22
Volume0.00
Average Volume (3M)N/A
Market Cap
$2.34M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,541,549,299
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard Deviation0.27
R-Squared0.03
Alpha-0.25
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.14
Price to Sales (P/S)440.20
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Acerus Pharmaceuticals News
PremiumPress Releases
Acerus Update
PremiumPress Releases
Acerus UpdateASPCQ FAQ
What was Acerus Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Acerus Pharmaceuticals’s market cap?
Currently, no data Available
When is Acerus Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acerus Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Acerus Pharmaceuticals overvalued?
According to Wall Street analysts Acerus Pharmaceuticals’s price is currently Overvalued.
Does Acerus Pharmaceuticals pay dividends?
Acerus Pharmaceuticals does not currently pay dividends.
What is Acerus Pharmaceuticals’s EPS estimate?
Acerus Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acerus Pharmaceuticals have?
Currently, no data Available
What happened to Acerus Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Acerus Pharmaceuticals?
Currently, no hedge funds are holding shares in ASPCQ
---
Company Description
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corp. engages in the development, manufacture, production, marketing, and distribution of women's and men's health products. It focuses on therapeutics for urology, hormone replacement therapy, and female dysfunction. Its products include Estrace, Natesto, Gynoflor, and Tefina. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus, and Mark L. Thompson in October 2008 and is headquartered in Mississauga, Canada.
---
Technical Analysis
---